Pfizer: Booster shots were 95.6% effective in Phase 3 trials

Pfizer noted that a portion of the trial took place while the spread of the more contagious delta variant was prevalent.

Related Keywords

United States , Americans , Albert Bourlam , Centers For Disease , Pfizer , Drug Administration , Disease Control , Booster Shots Pfizer , Covid 19 Vaccine , Pfizer Booster Shots , Pfizer Boosters , Pfizer Covid 19 Vaccines , Pfizer Vaccine , Pfizer Vaccine Booster ,